Advanced in Atrioventricular Nodal Reentrant Tachycardia (AVNRT)

Lei Y. Ding

600 South Wan Ping Road, 
Shanghai, CN 
Advanced in Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
600 South Wan Ping Road, 
Shanghai, CN 
OverviewLocationsClinical Research

Overview

Lei Ding practices in Shanghai, China. Ms. Ding is rated as an Advanced expert by MediFind in the treatment of Atrioventricular Nodal Reentrant Tachycardia (AVNRT). Her top areas of expertise are Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Osteosarcoma, Colorectal Cancer, Cardiac Ablation, and Hepato-Pancreato-Biliary Surgery.

Her clinical research consists of co-authoring 533 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 4 articles in the study of Atrioventricular Nodal Reentrant Tachycardia (AVNRT).

Gender
Female

Locations

600 South Wan Ping Road, Shanghai, 200030, China
Other Locations
Key Laboratory Of Carcinogenesis And Translational Research, Beijing, China
300 Guangzhou Road, Nanjing, 210009, China
Binhai Road 72, Qingdao, 266237, China
59 Hudong Road, Maanshan, 243002, China
N1 Shangcheng Road, Yiwu, China
Longhang Road, Zhujing, 201508, China
China Japan Union Hospital of Jilin University
Changchun, 130033, China
No.11 East Road, North 3rd Ring Road, Beijing, 100029, China
NO.1508, Longhang Road, Zhujing, China
126 Xinmin Street, Changchun, 130021, China
388 Lumo Road, Wuhan, 430074, China
58 Zhongshan 2nd Road, Guangzhou, 510080, China
81 Meishan Road, Hefei, 230032, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 2 Clinical Study to Evaluate the Safety and Efficacy of PA9159 Nasal Spray for the Treatment of Seasonal Allergic Rhinitis
A Phase 2 Clinical Study to Evaluate the Safety and Efficacy of PA9159 Nasal Spray for the Treatment of Seasonal Allergic Rhinitis
Enrollment Status: Completed
Publish Date: February 01, 2023
Intervention Type: Drug
Study Drug: PA9159
Study Phase: Phase 2

533 Total Publications

Total Synthesis of (±)-Larutienine B and (±)-Melokhanine B, D, E, F, and H.
Total Synthesis of (±)-Larutienine B and (±)-Melokhanine B, D, E, F, and H.
Journal: Organic letters
Published: October 06, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Ding's expertise for a condition
ConditionClose
      View All 9 Advanced Conditions
      View All 65 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile